Model
Edge
NRX Pharmaceuticals Inc.
0001864871
Filing Type
4
Filing Date
11/21/2022
Updated
11/22/22, 10:44 AM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership